title: Lymphoscintigraphy in breast cancer patients--comparison of peritumoural and intradermal injection.
abstract: AIM of this study was to determine whether the sentinel lymph nodes (SLNs) can be accurately identified in breast cancer patients with intradermal injection of the radiotracer above the primary tumour in comparison to peritumoural injection.
  
  
  METHODS
  In 45 women with breast cancer we performed lymphoscintigraphy on two separate days. We injected Tc-99m nanocolloid on the first day peritumourally, and on a separate day intradermally. The results of both investigations using different injection sites were compared in order to determine the number and location of SLNs.
  
  
  RESULTS
  The SLN identification rate using peritumoural injection was 71% (32 of 45 patients) and 96% (43 out of 45 patients) using intradermal injection. In 62% (28 of 45 patients) the number and location of the SLNs were identical. In 97% (31 of 32 patients) in whom a SLN was detected using peritumoural injection, the same SLNs reappeared with intradermal injection. There were no false negative findings with the peritumoural administration of tracer whereas the intradermal administration approach resulted in a false negative rate of 13%.
  
  
  CONCLUSIONS
  In women with breast cancer the reproducibility of lymphoscintigraphy using peritumoural and intradermal injection sites was 62%. The intradermal injection modality enables the detection of a SLN in patients where the peritumoural injection failed but it has the disadvantage of a higher false negative rate in comparison to the peritumoural injection technique.
authors.affiliation: Institut für Nuklearmedizin und Endokrinologie, Landeskliniken Salzburg, Austria. L.Rettenbacher@lkasbg.gv.at
authors.forename: L
authors.initials: L
authors.lastname: Rettenbacher
authors.forename: H
authors.initials: H
authors.lastname: Kässmann
authors.forename: G
authors.initials: G
authors.lastname: Galvan
authors.forename: C
authors.initials: C
authors.lastname: Menzel
authors.forename: R
authors.initials: R
authors.lastname: Reitsamer
authors.forename: J
authors.initials: J
authors.lastname: Holzmannhofer
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology; D005188:False Negative Reactions; D005260:Female; D006801:Humans; D007267:Injections; D007271:Injections, Intradermal; D008198:Lymph Nodes / Q000000981:diagnostic imaging*; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000008:administration & dosage*; D015203:Reproducibility of Results; D013668:Technetium Tc 99m Aggregated Albumin / Q000008:administration & dosage*
chemical_list: D019275:Radiopharmaceuticals; D013668:Technetium Tc 99m Aggregated Albumin; C083602:technetium Tc 99m nanocolloid